Results 11 to 20 of about 507,096 (126)
Human Vaccines & Immunotherapeutics, 2017 One hundred and ninety eight females aged 12–15 y were enrolled in an observer-blinded randomized trial to assess the immunogenicity and reactogenicity of the tetravalent HPV vaccine Gardasil® (group 2), in comparison to the bivalent HPV vaccine ...
Tao Haskins-Coulter +3 more
doaj +2 more sources
Human Vaccines & Immunotherapeutics, 2018 Human papillomavirus (HPV) infection is a frequent cause of malignant and non-malignant disease, in particular among persons with HIV. HPV serotype-specific anti L1 antibodies protect against HPV infection but little is known about prophylactic HPV ...
Maria Zurek Munk-Madsen +7 more
doaj +2 more sources
Prevalence, Characteristics, and Distribution of Human Papillomavirus According to Age and HIV Status in Women of Eastern Cape Province, South Africa [PDF]
VirusesHuman papillomavirus (HPV) is a sexually transmitted infection associated with the development of cervical cancer. This study investigated cervical HPV prevalence, characteristics, and distribution according to age and human immunodeficiency virus (HIV ...
Zizipho Z. A. Mbulawa +4 more
doaj +2 more sources
Financing of Human Papillomavirus Vaccination in Africa: A Scoping Review. [PDF]
Health Sci RepABSTRACT Background and Aims Human papillomavirus (HPV) vaccination is a critical intervention for cervical cancer prevention in Africa; however, program uptake and scale‐up remain limited due to financing constraints. This scoping review mapped existing evidence on HPV vaccine financing in Africa, identifying prevailing funding mechanisms, cost ...
Aminu K +10 more
europepmc +2 more sources
Vaccines, 2023 Mozambique has one of the highest rates of cervical cancer in the world. Human papillomavirus (HPV) vaccination was introduced in 2021. This study evaluated the health and economic impact of the current HPV vaccine (GARDASIL® hereafter referred to as ...
Esperança Lourenço Guimarães +13 more
doaj +1 more source
PLoS ONE, 2022 Human papillomavirus (HPV) prevalence and genotype distribution data is important for HPV vaccine monitoring. This study investigated the prevalence and distribution of HPV genotypes in cervical lesions of unvaccinated women referred to Nelson Mandela ...
Zizipho Z A Mbulawa +4 more
doaj +2 more sources
Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
BMC Health Services Research, 2023 Background Africa has some of the highest cervical cancer incidence and mortality rates globally. Burkina Faso launched a human papillomavirus (HPV) vaccination programme for 9-year-old girls in 2022 with support from Gavi, the Vaccine Alliance (Gavi ...
Joël Arthur Kiendrébéogo +8 more
doaj +1 more source
Capsomer vaccines protect mice from vaginal challenge with human papillomavirus. [PDF]
PLoS ONE, 2011 Capsomers were produced in bacteria as glutathione-S-transferase (GST) fusion proteins with human papillomavirus type 16 L1 lacking the first nine and final 29 residues (GST-HPV16L1Δ) alone or linked with residues 13-47 of HPV18, HPV31 and HPV45 L2 in ...
Wai-Hong Wu +7 more
doaj +1 more source
Adjuvants in vaccines registered for human use [PDF]
Arhiv za farmaciju, 2019 Vaccination is one of the most efficient strategies for prevention of infection diseases, but with introduction of sub-unit vaccines with lower immunogenicity adjuvants were needed to enhance the immune response.
Filipić Brankica +1 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2021 ContextIt has been more than 10 years since the human papillomavirus (HPV) vaccination program was initiated in most advanced countries. Thus, it seems necessary to change the uterine cervical cancer screening strategy.
Javier Freire-Salinas +8 more
doaj +1 more source